You are viewing: China In Vitro Fertilization Market analysis
Part of: In Vitro Fertilization Market (Global)

The China In Vitro Fertilization Market was valued at $110.7 Million in 2024 and projected to reach to $218.5 Million by 2029, representing a compound annual growth rate of 14.6%. China's in vitro fertilization market is positioned for sustained growth through 2029, with the market doubling from USD 110.7 million to USD 218.5 million.

China In Vitro Fertilization Market (2024-2029) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

China In Vitro Fertilization Market Trends and Insights

  • This growth trajectory reflects China's rising infertility rates, increasing healthcare spending, and government support for assisted reproductive technologies.
  • China's market is expanding faster than global averages, driven by urbanization, delayed childbearing, and improved access to fertility clinics across major cities. The Chinese IVF market benefits from a large patient population and growing awareness of reproductive health solutions.
  • China has invested significantly in fertility infrastructure, with numerous accredited clinics and research centers advancing treatment protocols.
  • By 2029, China is expected to consolidate its position as a leading regional market, supported by favorable demographic trends and regulatory frameworks that encourage fertility treatment adoption. China's competitive landscape includes both domestic and international fertility service providers.
  • The market's expansion is underpinned by technological innovation, rising disposable incomes, and evolving social attitudes toward assisted reproduction in China..

Key Market Statistics

  • CAGR (2024-2029) 14.6% CAGR
  • Market Size, 2024 ~USD 110.7 Million
  • Forecast, 2029 ~USD 218.5 Million
  • Country China

China In Vitro Fertilization Market Overview

Rapid Market Expansion :

China's IVF market is growing at 14.6% CAGR, significantly outpacing the global average of 11.7%, driven by rising infertility rates and increased healthcare accessibility across urban and semi-urban regions.

Government Support & Policy :

Chinese government initiatives promoting assisted reproductive technologies, including relaxed family planning policies and subsidies for fertility treatments, are accelerating market adoption and accessibility.

Rising Infertility Prevalence :

Urbanization, delayed marriage ages, and lifestyle factors have increased infertility rates in China, creating sustained demand for IVF services among the growing middle-class population.

Healthcare Investment Growth :

Increased healthcare spending and modernization of fertility clinics across major cities like Beijing, Shanghai, and Guangzhou are expanding treatment capacity and improving service quality.

China In Vitro Fertilization Market Dynamics

  • This expansion is underpinned by demographic shifts, government policy support for assisted reproduction, and rising disposable incomes enabling greater access to fertility treatments.
  • The market benefits from continuous clinic expansion and technological advancement in reproductive medicine. Looking ahead, China's IVF market will likely see consolidation among leading providers, increased adoption of advanced techniques like preimplantation genetic testing, and growing medical tourism inflows.
  • Regulatory improvements and insurance coverage expansion will further democratize access, particularly in tier-2 and tier-3 cities, ensuring the market maintains its above-average growth trajectory relative to global peers..

Related Ecosystem

In Vitro Diagnostics

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Enzyme-Linked Immunosorbent Assay (ELISA)
  • Dna Microarrays
  • Assay Kits
  • Microarrays
Top Companies
  • ROCHE HOLDINGS AG
  • Thermo Fisher Scientific Inc.
  • Danaher Corporation
  • Abbott Laboratories
  • Biomerieux s.a.

    Medical Devices

    Top Technologies
    • Polymerase Chain Reaction (PCR)
    • Magnetic Resonance Imaging (MRI)
    • Disposable Autoinjectors
    • Pulse Oximeters
    • Blood Pressure Monitors
    Top Companies
    • Medtronic plc
    • Abbott Laboratories
    • Stryker Corporation
    • Becton, Dickinson and Company
    • CONMED Corporation

      Key Takeaways

      • China's IVF market is projected to nearly double from USD 110.7 million in 2024 to USD 218.5 million by 2029, representing a 14.6% CAGR.
      • China's market growth outpaces global IVF expansion, driven by rising infertility rates and increased healthcare accessibility across urban centers.
      • Government support and regulatory frameworks in China are accelerating adoption of assisted reproductive technologies among the population.
      • China's expanding middle class and rising disposable incomes are fueling demand for premium fertility treatment options and specialized clinics.

      In Vitro Fertilization Market Report Scope

      Report Metric Details
      Base Year 2024
      Fastest Growing Segment FROZEN NON-DONORS (Type)
      Forecast Period 2024-2029
      Growth Rate CAGR of 11.7% from 2024 to 2029
      Largest Segment EQUIPMENT (Product)
      Market Size Base Year (Billions) ~USD 0.95 (2024)
      Revenue Forecast (Billions) ~USD 1.65 (2029)
      Segments Covered Product, Type, Type Of Cycle, Procedure, End User

      China In Vitro Fertilization Market Report Segmentation

      5 segment dimensions are covered across the global market.

      By Product

      • Accessories
      • Anti-Vibration Tables
      • Cabinets
      • Cryosystems
      • Equipment
      • Gas Analyzers
      • Imaging Systems
      • Incubators
      • Laser Systems
      • Micromanipulator Systems
      • Microscopes
      • Other Equipment
      • Ovum Aspiration Pumps
      • Reagents & Media
      • Sperm Analyzer Systems
      • Sperm Separation Systems
      • Witness Systems

      By Type

      • Anti-Vibration Tables
      • Cabinets
      • Cryopreservation Media
      • Cryosystems
      • Embryo Culture Media
      • Gas Analyzers
      • Imaging Systems
      • Incubators
      • Laser Systems
      • Micromanipulator Systems
      • Microscopes
      • Other Equipment
      • Other Incubators
      • Ovum Aspiration Pumps
      • Ovum Processing Media
      • Sperm Analyzer Systems
      • Sperm Processing Media
      • Sperm Separation Systems
      • Time-Lapse Incubators
      • Witness Systems

      By Type Of Cycle

      • Fresh Donors
      • Fresh Non-Donors
      • Frozen Donors
      • Frozen Non-Donors

      By Procedure

      • Conventional Ivf
      • Ivf With Donar Eggs
      • Ivf With Icsi
      • Minimal Ivf
      • Other Procedures

      By End User

      • Cryobanks
      • Fertility Clinics & Ivf Centers
      • Hospitals & Surgical Centers
      • Hospitals & Surgical Clinics
      • Research Institutes

      Target Audience

      • Fertility Clinic Operators : Clinic owners and administrators need China market data to benchmark performance, identify expansion opportunities in emerging cities, and understand competitive positioning within the rapidly growing domestic market.
      • Medical Device & Diagnostics Manufacturers : IVF equipment and diagnostic companies require market sizing and growth forecasts to prioritize China as a distribution market, plan product localization, and allocate sales resources effectively.
      • Healthcare Investment Firms : Private equity and venture capital investors evaluating fertility sector opportunities need validated market data, growth trajectories, and policy context to assess investment returns and portfolio company valuations.
      • Pharmaceutical Companies : Fertility drug manufacturers and biotech firms need China-specific market intelligence to forecast demand for hormonal therapies, plan clinical trials, and develop market entry strategies for reproductive health products.
      • Healthcare Consultants & Advisors : Strategy consultants and business advisors serving healthcare clients require authoritative China IVF market data to support client recommendations, competitive analyses, and market opportunity assessments.

      Reasons to Buy this Report

      • Market Size & Growth Validation : Obtain precise market valuation (USD 110.7M in 2024) and verified forecast data (USD 218.5M by 2029) to support investment decisions and competitive positioning in China's high-growth IVF sector.
      • Regional Performance Benchmarking : Compare China's 14.6% CAGR against global 11.7% average to identify outperformance drivers and replicate success factors across your fertility service portfolio or medical device offerings.
      • Policy & Regulatory Insights : Understand government support mechanisms, family planning policy impacts, and subsidy structures shaping market dynamics to navigate regulatory requirements and identify partnership opportunities.
      • Demand Driver Analysis : Access detailed analysis of urbanization effects, infertility prevalence trends, and healthcare spending patterns to identify high-potential customer segments and geographic expansion opportunities.
      • Strategic Market Entry Planning : Leverage comprehensive China-specific market intelligence to develop go-to-market strategies, clinic partnership models, and service offerings aligned with local demand and competitive landscape.

      Frequently asked questions

      What is the current size of China's IVF market?

      China's in vitro fertilization market was valued at USD 110.7 million in 2024 and is expected to grow to USD 218.5 million by 2029.

      What is the projected growth rate for China's IVF market?

      China's IVF market is expected to grow at a compound annual growth rate (CAGR) of 14.6% from 2024 to 2029.

      What factors are driving growth in China's IVF market?

      Key drivers include rising infertility rates, urbanization, delayed childbearing, government support for assisted reproductive technologies, and increased healthcare spending in China.

      How does China's IVF market compare to global growth?

      China's IVF market is growing at 14.6% CAGR, which exceeds the global average of 11.7%, positioning China as a high-growth regional market.

      What is the competitive landscape in China's IVF market?

      China's IVF market includes domestic fertility clinics, international service providers, and research institutions, with competition intensifying around treatment innovation and patient accessibility.

      RESEARCH METHODOLOGY

      In this research, the utilization of both primary and secondary sources was done to a great extent. This included studying the factors affecting the industry to find out the segmentation types, industry trends, key players, competitive landscape, key market dynamics, and strategies by key players.

      Secondary Research

      The secondary research process involves methods using directories, databases such as D&B Hoovers, Bloomberg Businessweek, Factiva, white papers, annual reports, company filings, investor presentations, and SEC filings, and collation of the database of industry leaders. This would help in fleshing out basic information on key players and market segmentation based upon the trends of the industry at various levels, major developments in the market, and technological perspectives pertaining to the in vitro fertilization market.

      Primary Research

      Primary research for this report featured interviews with a cross-section of sources from both the supply and demand sides to generate qualitative and quantitative data. On the supply side, there were primary sources from industries represented by CEOs, vice presidents, marketing and sales directors, regional sales managers, technology and innovation directors, and other key executives from leading companies and organizations in product therapy markets. Primary sources on the demand side included but were not limited to: embryologists, clinicians, procurement managers, purchase managers, department heads, and professionals from hospitals, fertility clinics, in vitro fertilization centers, and reference labs, among others. This primary research was hoped to validate market segmentation, identify key market players, and get an overview of the key trends and dynamics of the industry.

      A breakdown of the primary respondents is provided below:

      In Vitro Fertilization Market Size, and Share

      To know about the assumptions considered for the study, download the pdf brochure

      *Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.

      Note: Companies are classified into tiers based on their total revenue. As of 2023, Tier 1 = >USD 1  billion, Tier 2 = <USD 500 million, and Tier 3 = <USD 100 million.

      Market Estimation Methodology

      This report also presents the key players' revenue share analysis for the size of the in vitro fertilization market. The identification of key market participants and insights about their revenues in the in vitro fertilization sector are gathered through phases of primary and secondary research. The secondary research process relied heavily on top players' annual and financial reports, while primary research involved highly exhaustive interviews with key opinion leaders, viz., CEOs, directors, and senior marketing executives.

      The methodology adopted to calculate the global market value was on a segment basis. These segmental revenues were then sourced through the revenue data of major solution and service providers. The steps involved in the process are

      • Draw up a list of key global players operating in the in vitro fertilization market. Map the annual revenues accrued by players from the in vitro fertilization market or nearest reported business unit/ product category.
      • It represents the current major share of the global market as of 2022, using revenue mapping of the key players.

      Extrapolation to the global value for the in vitro fertilization market. Global In vitro fertilization Market: Bottom-Up Approach

      In Vitro Fertilization Market Size, and Share

      To know about the assumptions considered for the study, Request for Free Sample Report

      Global In vitro fertilization Market : Top-Down Approach

      In Vitro Fertilization Market Size, and Share

      In Vitro Fertilization Market Size, and Share

      Data Triangulation

      The in vitro fertilization market was segmented under various categories and subcategories using the above-mentioned methodology. Thereafter, proper data triangulation and the market segmentation process are carried out to further increase the accuracy of the data for each segment. Factors and trends from both the demand and supply sides were studied. Rigorous employment of both top-down and bottom-up approaches provided the result of the analysis of the in vitro fertilization market.

      Market Definition

      The in vitro fertilization market refers to the global landscape of Assisted Reproductive Technologies services and products that help a person or a couple conceive. It is a market that represents fertility clinics, hospitals, and even research institutions that provide in vitro fertilization treatments and related services, including medical devices, laboratory equipment, drugs, and consumables used for in vitro fertilization procedures. It also includes the diagnostic tests carried out prior to and in the course of in vitro fertilization, genetic screening technologies, and cryopreservation services. In vitro fertilization market has been used as a generic term describing the portfolio of diverse technologies, services, and products relating to the alleviation of infertility and the promotion of reproductive health.

      Key Stakeholders

      • Manufacturers and distributors of In vitro fertilization devices
      • Healthcare institutions (Hospitals and clinics)
      • Surgical centers
      • Healthcare institutions (hospitals and cardiac centers)
      • Research institutions
      • Clinical research organizations
      • Academic Medical Centers and Universities
      • Reference labs
      • Clinical research organizations
      • Accountable Care Organizations (ACOs)
      • Research and consulting firms
      • Contract research organizations (CROs) and contract manufacturing organizations (CMOs)
      • Academic medical centers and universities
      • Market research and consulting firms
      • Surgery Centers
      • Group Purchasing Organizations (GPOs)
      • Medical Research Laboratories
      • Academic Medical Centers and Universities

      Objectives of the Study

      • Define, describe, and forecast the In vitro fertilization market on Product, cycle, procedure, end user and region.
      • Analyze opportunities in the market for stakeholders and details of the competitive landscape for market leaders.
      • Detailed information regarding major factors influencing the market growth.
      • Analysis of the micro markets with respect to individual growth trends, prospects, and contribution to the total market.
      • Tracking and analysis of competitive developments such as new product launches and approvals, agreements, partnerships, expansions, acquisitions, and collaborations in the in vitro fertilization market.
      • Description of key companies operating in the market along with their market share analysis and core competencies

      Available Customizations

      With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the present global In vitro fertilization market

      Product Analysis

      • Product matrix, which gives a detailed comparison of the product portfolios of the top 5 companies.

      Company Information

      • Detailed analysis and profiling of additional market players (up to 5)

      Geographic Analysis

      • Further breakdown of the Rest of Europe's In vitro fertilization market: Russia, Belgium, the Netherlands, Switzerland, Austria, Finland, Sweden, Poland, and Portugal among other
      • Further breakdown of the Rest of Asia Pacific In vitro fertilization market Singapore, Taiwan, New Zealand, Philippines, Malaysia, and other APAC countries
      • Further breakdown of the Rest of the world In vitro fertilization market: Latin America, MEA, and Africa

      Get the Full In Vitro Fertilization Market Report

      Full forecast, segment splits, and company analysis for all In Vitro Fertilization Market.

      Need a Tailored Report?

      Customize this report to your needs

      Get 10% FREE Customization

      Customize This Report
      Fact checked
      DMCA.com Protection Status